Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs

Huang, H; Zhou, W; Zhu, HY; Zhou, P; Shi, XL

Shi, XL (reprint author), Fudan Univ, Sch Pharm, Dept Microbiol & Biopharm, 826 Zhangheng Rd, Shanghai 201203, Peoples R China.

TOXICOLOGY AND APPLIED PHARMACOLOGY, 2017; 323 ( ): 36

Abstract

Background: Although current antiviral treatments (nucleoside analogs, NAs) for chronic hepatitis B virus (HBV) infection are effective in suppressing......

Full Text Link